Skip to main content

Advertisement

Table 1 Characteristics of eligible studies

From: Comparison of atopy patch testing to skin prick testing for diagnosing mite-induced atopic dermatitis: a systematic review and meta-analysis

Study Country Cohort age (mean ± SD years) (range) Number of patients (n, female/male) Mite species (supplier) TP FP FN TN
Heinemann et al. [23] Germany 25.4 (18–43) 52 (37/15) D. pteronyssinus (ALK-Scherax-Arzneimittel) 13 1 10 28
Wistokat-Wülfing et al. [24] Germany NR 32 (NR) D. pteronyssinus (ALK-Scherax-Arzneimittel) 14 3 7 8
Lorenzini et al. [25] Brazil 9.47 (2–31) 43 (NR) A. ovatus (in house) 0 6 7 30
Darsow et al. [26] Germany 29 ± 16 (3-69) 36 (27/9) D. pteronyssinus (Bencard, Allergopharma) 8 5 12 11
Kutlu et al. [31] Turkey 6.9 ± 3.6 (2– 15) 44 (23/21) D. pteronyssinus (ALK-Abello, Stallergėnes) 7 2 11 24
Manzini et al. [27] Italy (0.5– 63) 313 (NR) D. pteronyssinus and D. farina (Bayropharm, Lofarma, Allergopharma 46 76 54 137
Wananukul et al. [28] Thailand (2–14) 30 (NR) D. pteronyssinus (GREER) 21 0 8 1
Michel et al. [29] Switzerland 35.8 (14–73) 23 (16/7) D. pteronyssinus (Stallergėnes*) 6 5 5 7
Holm [22] Sweden 29 (18–65) 81 (54/27) D. pteronyssinus and D. farina (ALK-Abello) 14 23 5 39
Fuiano et al. [30] Italy 2.2 ± 2.5 15 (NR) Dermatophagoides (Stallergėnes*) 1 11 0 3
  1. NR not reported. * Stallergėnes merged with GREER in 2015